Other exciting new discoveries include evidence that elevated Lp(a) levels likewise are a causal risk factor for aortic valve calcification and stenosis (4,5).
In aortic valve stenosis, thickening of the aortic valve cusps limits the outflow of blood from the left ventricle of the heart, a condition that, if untreated, can lead to heart failure and premature death. Aortic valve stenosis affects w2% of individuals $65 years of age, and in those who have symptoms, 5-and 10-year mortality approaches 50% and 90%, respectively, without aortic valve replacement (AVR) (6) . Ran- Braun, Kaneka, Amgen, Lilly, and Denka Seiken. Dr. Langsted has reported that she has no relationships relevant to the contents of this paper to disclose.
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physiological way, whereas very high Lp(a) levels could pathologically lead to aortic valve stenosis (4, 5) and atherosclerotic stenosis (7) . That said, the precise molecular mechanism by which elevated levels of Lp(a) may promote cholesterol deposition, thrombosis, and/or wound healing, eventually causing aortic valve and atherosclerotic stenosis, is not well understood.
In this issue of the Journal, Capoulade et al. (14) report on 220 patients with mild-to-moderate aortic valve stenosis who were followed for 3.5 years, observing that both elevated levels of Lp(a) and elevated levels of oxidized phospholipids on apolipoprotein B are associated with increased progression of aortic valve stenosis. These are novel, timely, and important findings. As oxidized phospholipids are carried mainly by Lp(a) (15) , it is speculated that Lp(a)
as an independent predictor of aortic valve stenosis could be explained by oxidized phospholipids (14) . Denmark. E-mail: Boerge.Nordestgaard@regionh.dk.
